health news today obesity drugs glp-1 New Pill Foundayo (Orforglipron) Gets FDA Approval for GLP-1 Weight Loss Drugs: Who

The gut-heart axis: updated review for the roles of microbiome in cardiovascular health

But Medicare coverage could have a bigger impact on who gets the drugs because the program covers about 66 million people, and is the primary source of insurance for people ages 65 and above

Ethics declarations Competing interests A.C.: AstraZeneca, Eli Lilly, Novo Nordisk, Roche Diagnostics, Sanofi Aventis

doi:10.1146/annurev.pharmtox.45.120403.095857 [PubMed] 15

Pancreatic cancer: slow progression in the early stages

The natural remedies we use for patients, on the other hand, treat the root cause of hypothyroidism for long-lasting results, and better improvement of symptoms than medication alone